baber/WOPTO huggingface dataset:
Patent DK-1293721-T3 (DK)
Inventor: RANTALAINEN JANNE
IPC: F16L55/115
Filed: 2002-09-12
Granted: 2004-12-20
Abstract: The invention relates to an end cap for a piping element comprising at least one flow pipe (1), insulation (2) arranged on the outside of the flow pipe (1) and an outer layer (3) arranged on the outside of the insulation (2). The end cap (4) comprises a side wall (10) to be arranged against the outer layer (3), a front surface (9) arranged against the insulation (2) and at least one sleeve (8) on the front surface (9). The flow pipe (1) is to be mounted through the sleeve (8). The end cap (4) is made at least partly resilient. <IMAGE>
Patent DK-1392347-T3 (DK)
Inventor: AVERBACK PAUL A
IPC: A61P25/00
Filed: 2002-05-16
Granted: 2005-12-12
Abstract: Disclosed is a method of preventing, inhibiting, and/or ameliorating cell death and/or tissue necrosis in live tissue by contacting live tissue with at least a segment of NTP, or homologue, variant, derivative or mimetic thereof, where the segment of NTP, or homologue, variant, derivative or mimetic thereof is present in an amount effective to prevent, inhibit, and/or ameliorate cell death and/or tissue necrosis. The method is capable of treating conditions requiring prevention, inhibition, and/or amelioration of cell death and/or tissue necrosis.
Patent DK-1397167-T3 (DK)
Inventor: ONIS SIMON
IPC: A61P7/04
Filed: 2002-05-09
Granted: 2010-06-07
Abstract: A wound closure system and methods utilizes a patient's own blood. The system preferably includes a chamber with a needle and a plunger for transferring and storing blood prior to surgery and the use of reversible anticoagulants. The chamber is pre-loaded with a reversible anticoagulant to prevent the blood from clotting during storage. When the surgery is complete, a counteracting agent is mixed with the withdrawn blood to counteract the reversible anticoagulant and allow the blood to clot. The clottable blood is then reintroduced into the patient to close a wound.
Patent DK-1358812-T3 (DK)
Inventor: AXT MATTHIAS
IPC: A43B7/24
Filed: 2003-05-02
Granted: 2005-07-25
Abstract: The insole is shaped to fit inside the shoe with curved edges (9,11) at the heel (1) and in the region of the toes. There is a round depression (7) at the ball of the foot and a round thickened portion of the sole (10) at the heel surrounded by a low ridge (8). There is a thickened portion (3) along the inside of the foot, and two separate thickened portions (4,5) along the outside of the foot (2).
Patent DK-1569696-T3 (DK)
Inventor: GARREN HIDEKI
IPC: A01N43/04
Filed: 2003-11-21
Granted: 2010-11-15
Abstract: This invention relates to methods and compositions for treating or preventing disease comprising the administration of immune modulatory nucleic acids having one or more immune modulatory sequences (IMSs). The invention further relates to the means and methods for the identification of the IMSs for preventing or treating disease, more particularly the treatment and prevention of autoimmune or inflammatory diseases. The invention also relates to the treatment or prevention of disease comprising the administration of the immune modulatory nucleic acids alone or in combination with a polynucleotide encoding self-protein(s), -polypeptide(s) or -peptide(s). The present invention also relates to methods and compositions for treating diseases in a subject associated with one or more self-protein(s), - polypeptide(s) or -peptide(s) that are present in the subject and involved in a non-physiological state.
Patent DK-1493817-T3 (DK)
Inventor: VOS PIETER
IPC: A01H5/10
Filed: 1997-08-08
Granted: 2011-03-28
Abstract: All or part of a 9870 bp nucleic acid sequence (I), or a sequence homologous to this sequence is claimed. More specifically, (I) is an approximately 9.9 kb sequence located around the AFLP marker PM14, this region comprises the Meloidogyne incognita (Mi) resistance gene (nucleotides 3263-7111 of the 9870 bp sequence which comprises two intronic sequences). The Mi resistance gene product has a sequence of 1257 amino acids (given in the specification).
Patent DK-1474990-T3 (DK)
Inventor: BESNARDEAU GUY
IPC: A23L3/375
Filed: 2004-05-06
Granted: 2006-07-24
Abstract: The procedure consists of subjecting a parallelpiped block (1) of a frozen seafood product to two separate treatments with liquids, especially brine, at negative temperatures for different periods of time. The first treatment (2) uses brine (3) at a temperature (T1) of -2 to -6 degrees C for a time (t1) of between 2 and 5 minutes to separate the frozen items. The second (4) uses brine (5) at a temperature (T2) of -18 to -22 degrees C for a time (t2) of between 2 and 4 minutes so that the separated items reach their optimum preservation temperature. The brine treatmenyts can be carried out by spraying or immersion combined with bubbling, and after separation the items (1) are weighed and packed in batches (8) for transport, storage or sale.
Patent DK-1708679-T3 (DK)
Inventor: ROGUEDA PHILIPPE
IPC: A61K31/573
Filed: 2004-11-24
Granted: 2009-02-16
Abstract: Novel Formulations Partially and fully acylated cyclodextrins have been found to be soluble in HFA propellants, and therefore can be used to formulate stable HFA pMDIs both as suspensions and solutions.
Patent DK-1617418-T3 (DK)
Inventor: LILJERYD LARS
IPC: G10L25/18
Filed: 2000-01-26
Granted: 2008-09-01
Abstract: The present proposes new methods and an apparatus for enhancement of source coding systems utilising high frequency reconstruction (HFR). It addresses the problem of insufficient noise contents in a reconstructed highband, by Adaptive Noise-floor Addition. It also introduces new methods for enhanced performance by means of limiting unwanted noise, interpolation and smoothing of envelope adjustment amplification factors. The present invention is applicable to both speech coding and natural audio coding systems.
Patent DK-1733111-T3 (DK)
Inventor: KAISER KONRAD
IPC: E05B17/20
Filed: 2005-04-07
Granted: 2007-11-05
Abstract: A window or door including a circumferential blind frame and a leaf with a surface element is provided, which can be pivoted about one or more axes in relation to the blind frame, as well as including fittings, located between the leaf and the blind frame, which are used for moving the leaf in relation to the blind frame. Electromechanically actuated locking elements are provided for locking the leaf into the blind frame. Each locking element has its own electromechanical drive, and/or the locking elements are configured such that, when the window is closed, they are displaced in relation to the pane plane, thus pressing the leaf perpendicularly against the blind frame with a predetermined contact force.
Patent DK-1897408-T3 (DK)
Inventor: ONG KAH HOOI VINCENT
IPC: H04R25/00
Filed: 2005-06-25
Granted: 2011-05-30
Abstract: The invention relates to a hearing aid device and a hearing aid switch. The switch is operable to open and close an electric circuit of the hearing aid device. A lock for the switch is operable to selectively enable and disenable a hearing aid device function. The hearing aid device comprises a device for selectively inhibiting the operation of the switch to enable or to disenable the hearing aid device function.
Patent DK-1789204-T3 (DK)
Inventor: CALGUA ERWIN
IPC: B05B3/08
Filed: 2005-09-10
Granted: 2010-03-29
Abstract: An apparatus for application of liquids to a continuously conveyed outer layer having a rotating plate which is horizontal and parallel to the outer layer or with a deviation of up to 15° from horizontal, wherein a liquid applied to the rotating plate is ejected centrifugally from the rotating plate via rotation and then, via gravity, passed onto the outer layer below the rotating plate, is provided.
Patent DK-1869327-T3 (DK)
Inventor: BRAUN FRANCOIS
IPC: F04F1/02
Filed: 2006-03-16
Granted: 2009-08-24
Abstract: A method and a device for extracting a liquid from a liquid pond, wherein in a first phase air is removed from an airtight reservoir, a venting and a rising pipe in order to create depression therein and a suck-up of the liquid in the liquid pond. In a second phase, a distribution device is brought from a first to a second operating position in order to supply pressurised gas to said venting pipe which has an outlet connected to the rising pipe. In a third phase the liquid is pushed from the venting pipe to the rising pipe and thereafter to the reservoir by means of pressurised air and an interface member. In a fourth phase the distribution device is brought back to its first operation position.
Patent DK-1820977-T3 (DK)
Inventor: WALZ RUEDIGER
IPC: F16B12/20
Filed: 2007-02-05
Granted: 2011-12-12
Abstract: The connector for hollow panels, especially honeycomb and sandwich panels, comprises a fixing (2) which fits over the head of a screw. This is mounted in a sleeve (1) made up of two sections (5, 6) connected by a film hinge (7).
Patent DK-2023070-T3 (DK)
Inventor: HALBE VOLKER
IPC: F28D19/04
Filed: 2007-07-24
Granted: 2011-07-11
Abstract: The heat exchanger has a rotor (10) comprising a set of radially running sector walls (12). Heat accumulator chambers (19) are arranged one behind the other in a radial direction of the rotor and through-flowable by a gaseous medium. The chambers comprise openings formed in an area of front surfaces of the rotor, and a radial seal (20) is arranged at the front surfaces of the rotor, where the seal and the rotor are rotatable relative to each other. The radial seal is designed in such a manner that the seal partially covers the opening during the operation of the heat exchanger. An independent claim is also included for a method for separating gaseous medium in a regenerative-heat exchanger.
Patent DK-1950375-T3 (DK)
Inventor: JONSSON SVEIN
IPC: E21D11/10
Filed: 2006-06-30
Granted: 2010-07-05
Abstract: Construction has a seal secured at the outer side against traversing water or a anchor isolation against corrosion or a film with rough surface or a claw mat or an agent for spraying concrete with enclosed plastic foam particles. The film is held by means of sealing elements at the anchoring elements.
Patent DK-2014832-T3 (DK)
Inventor: ZUERCHER RALF
IPC: B61D15/00
Filed: 2008-03-28
Granted: 2011-04-26
Abstract: The device has a set of trolleys (1) inter-coupled one behind the other. Each trolley has a conveyor (7) provided between two adjacent trolleys, and another conveyor (6) extending over entire length of the trolley and arranged in a roof region of the trolley for unloading. The conveyer (6) is arranged in material conveying direction in a cascade-like manner. The two conveyers are positioned relative to each other such that the conveyer (7) places the material of the pulley provided at back of the direction on the conveyer (6) of the trolley that is provided in front of the direction.
Patent DK-2223115-T3 (DK)
Inventor: ROLLINGER WOLFGANG
IPC: G01N33/574
Filed: 2008-12-08
Granted: 2011-12-12
Abstract: The present invention relates to a method aiding in the assessment of cancer. It discloses the use of the human fibroblast activation protein (FAP/seprase) as a universal marker of different cancer types. Seprase aids in the assessment of pulmonary or lung cancer (LC) or of colon cancer, e.g., of non-small cell lung carcinoma (NSCLC) or colorectal cancer (CRC), but also likely of other specific types of cancer. Such specific cancer types are, e.g., esophagus, head and neck cancer, stomach cancer, bile duct cancer, pancreas cancer, kidney cancer, cervix cancer, ovary cancer, breast cancer, bladder cancer, endometrium cancer or prostate cancer. Furthermore, it especially relates to a method for assessing cancer from a liquid sample, derived from an individual by measuring seprase in said sample. Measurement of seprase can, e.g., be used in the early detection of cancer or in the surveillance of patients who undergo surgery.
Patent DK-2305800-T3 (DK)
Title: NOVEL Hypocrea JECORINA CBH CELLULASEVARIANTER
Inventor: DAY ANTHONY
IPC: C12N9/42
Filed: 2003-08-15
Granted: 2015-08-24
Abstract: Described herein are variants of H. jecorina CBHI, a Ce17 enzyme. The present invention provides novel cellobiohydrolases that have improved thermostability and reversibility.
Patent DK-2567139-T3 (DK)
Inventor: LOKKINEN MIKA
IPC: F16L55/18
Filed: 2011-05-03
Granted: 2018-09-03
Abstract: The invention relates to a method for preparing a resizing sleeve (1 1 1, 203) for lining a joining point in a pipe assembly comprising pipes of thicker (201 ) and thinner (202) diameter. The method is characterized in that it comprises the steps for stretching the resizing sleeve (1 1 1, 203) in diameter to the size of the thicker pipe (201 ) in diameter of the pipe assembly, installing an installation hat (1 10, 204) according to the thicker pipe (201 ) in diameter of the pipe assembly by airtightly gluing it onto the stretched resizing sleeve (1 1 1, 203), and returning the resizing sleeve (1 1 1, 203) to the size of the thinner pipe (202) in diameter of the pipe assembly to be lined. A suitable tool (100) for implementing the method is also presented.
Patent DK-2750704-T3 (DK)
Inventor: IVOK MARIANNA
IPC: C07K14/01
Filed: 2012-08-31
Granted: 2018-01-15
Abstract: The present invention relates to synthetic proteins and the uses thereof. More particularly, the invention relates to synthetic Circovirus type capsid proteins with improved properties. These proteins, or the coding nucleic acids, are useful e.g., to generate antibodies, immunogen compositions, or vaccines. The invention further relates to methods for treating and/or preventing PCV2-associated diseases in mammals using said proteins, nucleic acids or compositions. The invention also relates to compositions and methods for detecting PCV2 in a sample, using the above proteins, nucleic acids, or antibodies.
Patent DK-2863931-T3 (DK)
Inventor: BURMEISTER YVONNE
IPC: A61P17/02
Filed: 2013-06-18
Granted: 2018-02-12
Abstract: The present invention is concerned with plant and animal derived pharmaceutically useful compositions. In particular, it relates to a composition for use in treating wound healing, wherein said composition comprises Aranea diadematus, Calcium phosphoricum, Equisetum hiemale, Ferrum jodatum, Fumaria officinalis, Gentiana lutea, Geranium robertianum, Levothyroxinum, Myosotis arvensis, Nasturtium officinale, Natrium sulfuricum, Pinus silvestris, Sarsaparillae radix, Scrophularia nodosa, Teucrium scorodonia, and Veronica officinalis. Contemplated is also a medicament comprising said composition as well as a method for treating wound healing in a subject suffering therefrom, said method comprises administering in a therapeutically effective amount to the said subject a composition.
Patent DK-2965749-T3 (DK)
Inventor: CHOWHAN MASOOD A
IPC: A61P27/02
Filed: 2010-12-01
Granted: 2018-08-27
Abstract: The present invention generally relates to suspension compositions having a carboxyvinyl polymer such as a carbomer, a galactomannan such as guar, and a borate compound. A sparingly soluble particulate compound such as nepafenac is also included in the compositions. The sparingly soluble particulate compound has a small particle size to enhance bioavailability of the compound.
Patent DK-0405370-T3 (DK)
Inventor: PERKINS JOHN B
IPC: C12N15/52
Filed: 1990-06-22
Granted: 2000-12-27
Abstract: The present invention is directed to bacteria that overproduce riboflavin. The invention concerns the nucleotide sequence of the rib operon and its open reading frames, and recombinant bacteria that contain the rib operon. Specifically, the invention relates to bacteria that have been mutated so that their production of riboflavin and/or purines is deregulated, and which have copies of the rib operon inserted and amplified in their chromosomal DNA. In a specific embodiment, the rib operon itself can be deregulated by replacing its control regions with sequences that allow constitutive or unregulated expression. The bacteria, operons and sequences of this invention are used to overproduce relatively large amounts of riboflavin by fermentation. <IMAGE>
Patent DK-0380367-T3 (DK)
Inventor: YEH KUO-CHEN
IPC: A61K9/00
Filed: 1990-01-26
Granted: 1994-02-28
Abstract: Synergistic compositions comprising an antioxidant and an arylpropionic, non-steroidal anti-inflammatory drug used to treat certain diseases are disclosed. The compositions inhibit production of arachidonic acid cascade end-products which have been implicated as causes of tissue-destruction in periodontal disease. The compositions are administered in combination with a carrier, which may be a mucosal-tenacious polymer selected from the groups of semi-solid pastes, gels, ointments, liquids or films.
Patent DK-0419327-T3 (DK)
Inventor: PLAQUEVENT JEAN-CHRISTOPHE
IPC: C07C323/60
Filed: 1990-09-14
Granted: 1994-10-17
Abstract: Amino acid drivatives, enkephalinase and ACE inhibitors, of the formula (Ia) and (Ib), wherein R1 represents a biphenyl group or one of the groups (a), wherein Z, Y and n have the meanings (b) or (c), wherein R'1, represents a hydrogen atom, a lower alkyl group; a phenyl group; a lower phenylalkylene group. R2 represents a hydrogen atom; a lower alkyl group; a lower hydroxyalkylene group; a lower phenylalkylene group; a lower hydroxyphenylalkylene group; a lower aminoalkylene group; a lower guanidinoalkylene group; a lower mercaptoalkylene group; a lower thioalkylene lower alkyl group; a lower imidazolylkylene group; a lower indolylalkylene group; a lower carbamylalkylene group; a lower carboxyalkylene group or one of the groupings (d), where Z, Y and n have the meanings (e), X indicates a grouping responsible for chelating the zinc atom of enzymes, enkephalinase and ACE, and may be selected from the group which comprises a mercaptomethyl; hydroxamic acid; an N-carboxyalkyl of the formula (f), wherein R3 represents a benzyl lower alkyl radical, or a benzyl lower alkoxy radical; phosphorus-containing derivatives of the formula (g) or (h).
Patent DK-0422186-T3 (DK)
Inventor: BROWN THOMAS J
IPC: A61K47/48
Filed: 1990-04-09
Granted: 1999-08-16
Abstract: The present invention is directed to the use of a recently discovered cytokine, Oncostatin M, to control endothelial cell immunogenicity, fibrinolytic activity, proliferation and cytokine synthesis, and to its use in the treatment of a variety of human vascular and immune system disorders involving the vascular endothelium, as well as its use in the treatment of neoplastic disease. The method of the invention includes the use of mature, hybrid, modified or truncated forms of Oncostatin M as well as Oncostatin M analogs. The invention is described by way of examples in which the efficacy of such compounds is evaluated using various in vitro assay systems.
Patent DK-0492067-T3 (DK)
Inventor: LARWS PETER
IPC: A63H33/06
Filed: 1991-10-01
Granted: 1994-09-12
Abstract: A construction module is described, one side of which has four slightly resilient spring leaves (6, 6') which are arranged in a tulip shape and can easily snap onto the other five side faces (2 to 5) of an identical construction module. The side faces have strips (8, 8') which can be continuous or interrupted. On the inside, the spring leaves are provided with corresponding connecting elements (7, 7', 7'') which engage behind the said strips. A connection is produced between two construction modules firstly by slight deflection of the spring leaves from their position of rest and by subsequent engagement behind the said strips. The construction modules have the advantage that they can be connected to one another or detached from one another easily and reliably even after a long time and frequent use. <IMAGE>
Patent DK-0530446-T3 (DK)
Inventor: ULRICH HEINZ DR
IPC: A61K31/19
Filed: 1992-05-26
Granted: 1998-09-23
Abstract: Use of compounds of the formula <IMAGE> in which X is a hydrogen atom or both Xs are a single bond between the two sulphur atoms, and n is a number from 1 to 10, or the therapeutically utilisable salts thereof for the preparation of a medicament for combating pathophysiological excitatory disorders and related diseases as well as allergic disorders, and the preparation of corresponding medicaments.
Patent DK-0521551-T3 (DK)
Inventor: SCHIESARO PIERLUIGI
IPC: F25B49/02
Filed: 1992-06-24
Granted: 1995-07-24
Abstract: In a linear-power multi-compressor refrigeration system usable for different users, comprising a central refrigeration unit provided with a plurality of motor-compressor units (11,12,13) of different unit power arranged in parallel between a suction manifold (14) and a delivery manifold (15), there are provided an inverter (17) and an associated dedicated or programmable logic system (16), which selectively control the activation of the individual motor-compressor units (11,12,13) to achieve a linearly increasing and/or decreasing power, and maintain it equal to that required by the users. Preferably the motor-compressor units (11,12,13) are three in number, of which two (11,12) are of high power and one (13) is of low power. <IMAGE>
Patent DK-0565621-T3 (DK)
Inventor: COMINS DANIEL L
IPC: C07D491/052
Filed: 1991-12-18
Granted: 2000-10-09
Abstract: Compounds of Formula I <CHEM>  are made in accordance with the following scheme: <CHEM> wherein R may be loweralkyl; R1 may be H, loweralkyl, loweralkoxy, or halo; R2, R3, R4, and R5 may each independently be H, amino, hydroxy, loweralkyl, loweralkoxy, loweralkylthio, di(loweralkyl)amino, cyano, methylenedioxy, formyl, nitro, halo, trifluoromethyl, aminomethyl, azido, amido, hydrazino, or any of the twenty standard amino acids bonded to the A ring via the amino-nitrogen atom; Y is H and W and X are halogen. Also disclosed are novel processes for making starting materials for the scheme given above, and novel intermediates employed in these processes.
Patent DK-0558937-T3 (DK)
Inventor: JANCZAK ANDRZEJ
IPC: H01R4/24
Filed: 1993-02-02
Granted: 1996-02-05
Abstract: The invention relates to a cutting and clamping terminal element for contacting electrical conductors, in particular for cable cores of the telecommunication technology, comprising a U-shaped section piece of a U-shaped cross-section and having a cutting and clamping contact. In order to provide a cutting and clamping terminal element (1) by means of which a plurality of parallel electrical conductors (6) can be terminated and accurately positioned and guided, the U-shaped section piece (2) is adapted with one or several central webs (3), which are cut free from the bottom portion (7) and are upwardly bent off. Thereby one or more contact positions 9 are obtained for the electrical conductors (6).
Patent DK-0568916-T3 (DK)
Inventor: DAVIES BARRIE L
IPC: D04H1/48
Filed: 1993-04-28
Granted: 1999-02-08
Abstract: A tufted fabric (10) made of a partially meltable primary backing (12) and tufts (14) tufted into the primary backing. The tufts are bonded to the backing by either entanglement or partially melting the backing (12) to bond the tufts and applying a secondary backing (11) by either fusion bonding or entanglement. <IMAGE>
Patent DK-0595381-T3 (DK)
Inventor: DEMEUSE MARK T
IPC: C08F18/24
Filed: 1993-09-18
Granted: 1997-05-26
Abstract: Carbonate monomers are polymerized in the presence or absence of a polymerization initiator by irradiation with electromagnetic radiation in the absence of solvent or diluent. <IMAGE>
Patent DK-0602740-T3 (DK)
Inventor: PEETERS WIJNAND PETER HELENA
IPC: C12P41/00
Filed: 1993-12-13
Granted: 1999-09-27
Abstract: The invention relates to the preparation of an optically active ester of trans-3-phenylglycidic acid in which a mixture of the 2 enantiomers of the trans-3-phenylglycidic acid ester is stereoselectively hydrolyzed using an enzyme originating from Candida antarctica and the non-hydrolyzed ester is separated off from the reaction mixture. A racemic mixture of trans-phenylglycidic acid esters is selectively and enzymatically hydrolyzed in a relatively short reaction time, the residual ester being obtained in a high yield and with a high e.e. Such esters are used for the preparation of pharmaceuticals such as benzothiazepines and benzazepines.